Filing Details

Accession Number:
0001062993-22-019838
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-22 09:26:22
Reporting Period:
2022-09-21
Accepted Time:
2022-09-22 09:26:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1098880 Intelgenx Technologies Corp. IGXT Pharmaceutical Preparations (2834) 870638336
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1685324 Dana Matzen 4771 Rue Sherbrooke O.
Westmount A8 H3Z 1G5
Vp Bd & Corp.dev.of Subsidiary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, 0.00001 P.v. Acquisiton 2022-09-21 25,000 $0.14 75,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, 0.00001 P.v. 10,000 Indirect Held by spouse
Footnotes
  1. Acquired on TSX Exchange at C$0.185 per share